Current Status and Advances in the Diagnosis and Management of Gestational Diabetes Mellitus: An Analysis of Relevant Contents in the American Diabetes Association Standards of Care in Diabetes—2025

ZHANG Jiani, LIU Jiyuan, MAO Chihui, YU Haiyan, WANG Xiaodong

Abstract

Gestational diabetes mellitus (GDM) is closely associated with short-term and long-term adverse outcomes for both mothers and fetuses. In recent years, with the global prevalence of obesity and type 2 diabetes mellitus (T2DM) constantly rising, there is a significant increase in GDM incidence, with notable regional variations. Current challenges in GDM management include insufficient early screening or diagnosis, limited personalized intervention strategies, and poor adherence to long-term follow-up. Key research priorities for the future include optimizing screening methods for high-risk populations, enhancing targeted lifestyle interventions, and establishing effective follow-up and long-term health management systems. In December 2024, the American Diabetes Association (ADA) released the Standards of Care in Diabetes—2025 (hereafter referred to as ADA [2025]), providing updated perspectives on the diagnosis and treatment of diabetes mellitus, as well as an overview of the definition, screening and diagnostic criteria, and management strategies for GDM. Based on ADA (2025) and the circumstances of clinical practice in China, we summarized the latest advancements in GDM research, aiming to improve comprehensive management strategies to prevent, delay, and improve adverse outcomes associated with GDM.

 

Keywords: Gestational diabetes mellitus, American Diabetes Association (ADA), Disease management, Review

 

Full Text:

PDF


References


American Diabetes Association. 2. Diagnosis and classification of diabetes: standards of care in diabetes—2025. Diabetes Care, 2025, 48(Supplement_1): S27-S49. doi: 10.2337/dc25-S002.

ZHU H, ZHAO Z, XU J, et al. The prevalence of gestational diabetes mellitus before and after the implementation of the universal two-child policy in China. Front Endocrinol (Lausanne), 2022, 13: 960877. doi: 10. 3389/fendo.2022.960877.

YE W, LUO C, HUANG J, et al. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ, 2022, 377: e67946. doi: 10.1136/bmj-2021-067946.

HUANG J Q, LI Y T, LIU M Y, et al. Guide interpretation/contrast the guideline of gestational hyperglycemia from CMA and the guideline of gestational diabetes mellitus from ADA in 2022. J Int Obstet Gynecol, 2022, 6(49): 691-699. doi: 10.12280/gjfckx.20220262.

CHUME F C, RENZ P B, HERNANDEZ M K, et al. Is there a role for glycated albumin in the diagnosis of gestational diabetes mellitus?Endocrine, 2021, 72(3): 681-687. doi: 10.1007/s12020-021-02673-6.

ZHANG J, ZHOU F, XU T, et al. The diagnostic value of glycosylated hemoglobin for gestational diabetes mellitus in Asian populations: a systematic review and meta-analysis. J Obstet Gynaecol Res, 2022, 48(4): 902-911. doi: 10.1111/jog.15170.

American Diabetes Association. 15. Management of diabetes in pregnancy: standards of care in diabetes-2025. Diabetes Care, 2025, 48(Supplement_1): S306-S320. doi: 10.2337/dc25-S015.

ZHANG X, YU J, XIAO X H. Guidelines for the co-management of gestational diabetes mellitus in mothers and their offspring (2024 edition). Chinese Research Hospitals, 2024, 11(6): 11-31. doi: 10.19450/j.cnki.jcrh. 2024.06.003.

SWEETING A, WONG J, MURPHY H R, et al. A clinical update on gestational diabetes mellitus. Endocr Rev, 2022, 43(5): 763-793. doi: 10. 1210/endrev/bnac003.

HILLIER T A, PEDULA K L, OGASAWARA K K, et al. A pragmatic, randomized clinical trial of gestational diabetes screening. N Engl J Med, 2021, 384(10): 895-904. doi: 10.1056/NEJMoa2026028.

KAUFFMAN R P. 1-Step screening approach detected more GDM than 2-step approach but did not improve clinical outcomes. Ann Intern Med, 2021, 174(8): C93. doi: 10.7326/ACPJ202108170-093.

MORILAWA M, SUGIYAMA T, HIRAMATSU Y, et al. Screening methods for gestational diabetes mellitus in Japan in 2018: a retrospective cohort study using a national surveillance questionnaire. Endocr J, 2022, 69(11): 1313-1322. doi: 10.1507/endocrj.EJ22-0072.

ŞAHIN M, ÜMIT G, BILGI A, et al. Comparison of the effectiveness of screening methods for the diagnosis of gestational diabetes mellitus in pregnant women: a cross-sectional study. Int J Clin Pract, 2021, 75(11): e14857. doi: 10.1111/ijcp.14857.

MOON J H, JANG H C. Gestational diabetes mellitus: diagnostic approaches and maternal-offspring complications. Diabetes Metab J, 2022, 46(1): 3-14. doi: 10.4093/dmj.2021.0335.

LIU J Y. Comparison of two diagnostic methods for gestational diabetes mellitus. Chengdu: Sichuan University, 2021. doi: 10.27342/d.cnki.gscdu. 2021.007434.

METZGER B E, GABBE S G, PERSSON B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care, 2010, 33(3): 676-682. doi: 10.2337/dc09-1848.

UK NCCF. Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. London: National Institute for Health and Care Excellence (UK), 2015.

ACOG practice bulletin No.190: gestational diabetes mellitus. Obstet Gynecol, 2018, 131(2): e49-e64. doi: 10.1097/AOG.0000000000002501.

SACCONE G, KHALIFEH A, Al-KOUATLY H B, et al. Screening for gestational diabetes mellitus: one step versus two step approach: a meta-analysis of randomized trials. J Matern Fetal Neonatal Med, 2020, 33(9): 1616-1624. doi: 10.1080/14767058.2018.1519543.

MO X, GAI T R, TAKAHASHI Y, et al. Economic evaluations of gestational diabetes mellitus screening: a systematic review. J Epidemiol, 2021, 31(3): 220-230. doi: 10.2188/jea.JE20190338.

MALAZA N, MASETE M, ADDAM S, et al. A systematic review to compare adverse pregnancy outcomes in women with pregestational diabetes and gestational diabetes. Int J Environ Res Public Health, 2022, 19(17): 10846. doi: 10.3390/ijerph191710846.


Refbacks

  • There are currently no refbacks.